Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
KM

Kevin D. McCormick — 45 Patents

SCSchering: 27 patents #71 of 2,442Top 3%
Merck: 12 patents #936 of 9,382Top 10%
SPSchering-Plough Healthcare Products: 3 patents #49 of 322Top 20%
PDPharmacopeia Drug Discovery: 2 patents #88 of 193Top 50%
CFCornell Research Foundation: 2 patents #418 of 1,638Top 30%
CNCambridge Neuroscience: 1 patents #27 of 40Top 70%
PHPharmacopeia: 1 patents #139 of 211Top 70%
Berkeley Heights, NJ: #30 of 1,035 inventorsTop 3%
New Jersey: #1,118 of 69,400 inventorsTop 2%
Overall (All Time): #64,393 of 4,157,543Top 2%
45 Patents All Time
Kevin D. McCormick has been granted 45 US patents while listed as an inventor at Schering. The first was granted in 1993 and the most recent in November 2018. Kevin D. McCormick ranks #64,393 of 4,157,543 US inventors in our database (top 1.5%). Patent records list Kevin D. McCormick in Berkeley Heights, NJ, US.

Patents per Year

Patents granted per year, 1993 to 2018Bar chart with a peak of 7 patents in 2013.peak 71993: 1 patents19931995: 1 patents1997: 2 patents19971998: 3 patents1999: 4 patents19992000: 2 patents2004: 2 patents20042005: 2 patents2006: 1 patents20062007: 3 patents2008: 2 patents20082009: 3 patents2010: 3 patents20102011: 4 patents2012: 1 patents20122013: 7 patents2015: 1 patents20152016: 2 patents2018: 1 patents2018

Issued Patents All Time

Showing 1–25 of 45 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10138212 Aminoquinazoline compounds as A2A antagonist Amjad Ali, Rongze Kuang, Yeon-Hee Lim, Michael Man-Chu Lo, Pauline C. Ting +21 more 2018-11-27 $94,550,000
9469615 Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators Christopher W. Boyce, Sylvia Degrado, Xiao-Tao Chen, Jun Qin, Robert Mazzola +20 more 2016-10-18 $133,900,000
9290453 Quinolines and aza-quinolines as CRTH2 receptor modulators Christopher W. Boyce, Salem Fevrier, Anandan Palani, Robert G. Aslanian, Phieng Siliphaivanh +3 more 2016-03-22 $71,894,000
8927559 Quinazolinone-type compounds as CRTH2 antagonists Robert G. Aslanian, Christopher W. Boyce, Robert Mazzola, Brian McKittrick, Anandan Palani +20 more 2015-01-06 $93,479,000
8592383 Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators Xianhai Huang, Jason D. Brubaker, Scott Peterson, John W. Butcher, Joshua Close +12 more 2013-11-26 $55,727,000
8569312 Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators Li Dong, Christopher W. Boyce, Manuel de Lera Ruiz, Salem Fevrier, Jie Wu +12 more 2013-10-29 $46,137,000
8524697 C20-C21 substituted glucocorticoid receptor agonists John C. Anthes, John Hey, Robert G. Aslanian, Purakkattle Biju, Michael Y. Berlin +5 more 2013-09-03 $73,082,000
8501747 Functionally selective alpha2C adrenoreceptor agonists Manuel de Lera Ruiz, Christopher W. Boyce, Robert G. Aslanian, Younong Yu, Pietro Mangiaracina +5 more 2013-08-06 $72,172,000
8476274 Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators Li Dong, Christopher W. Boyce, Manuel de Lera Ruiz, Salem Fevrier, Jie Wu +12 more 2013-07-02 $146,162,000
8470863 Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists Junying Zheng, Jianhua Chao, Christopher W. Boyce, Robert G. Aslanian, Younong Yu 2013-06-25 $46,267,000
8383818 Functionally selective alpha2C adrenoreceptor agonists Junying Zheng, Jianhua Chao, Robert G. Aslanian, Mwangi W. Mutahi, Christopher W. Boyce +1 more 2013-02-26 $57,688,000
8324213 Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators Li Dong, Christopher W. Boyce, Manuel de Lera Ruiz, Salem Fevrier, Jie Wu +12 more 2012-12-04 $94,767,000
8017642 Functionally selective ALPHA2C adrenoreceptor agonists Younong Yu, Pietro Mangiaracina, Christopher W. Boyce 2011-09-13
8003624 Functionally selective ALPHA2C adrenoreceptor agonists Christopher W. Boyce, Younong Yu 2011-08-23
7985748 ALPHA2C adrenoreceptor agonists Christopher W. Boyce, Neng-Yang Shih, Robert G. Aslanian, Pietro Mangiaracina, Manuel de Lera Ruiz +7 more 2011-07-26
7879880 Substituted aniline derivatives useful as histamine H3 antagonists Daniel M. Solomon, Robert G. Aslanian, Michael Y. Berlin, Manuel de Lera Ruiz, Mwangi W. Mutahi +1 more 2011-02-01
7846946 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz +9 more 2010-12-07
7803828 Functionally selective alpha2C adrenoreceptor agonists Christopher W. Boyce, Robert G. Aslanian, Neng-Yang Shih, Salem Fevrier, Pietro Mangiaracina +4 more 2010-09-28
7700592 α2C adrenoreceptor agonists Christopher W. Boyce, Neng-Yang Shih, Chia-Yu Huang, Robert G. Aslanian, Salem Fevrier +8 more 2010-04-20
7638531 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists Mwangi W. Mutahi, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Manuel de Lera Ruiz +7 more 2009-12-29
7635705 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz +9 more 2009-12-22
7531660 1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereof Manuel de Lera Ruiz, Robert G. Aslanian, Michael Y. Berlin, Chander Shekher Celly 2009-05-12 $208,740,000
7408066 Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Ying Huang, Mwangi W. Mutahi, Neng-Yang Shih +3 more 2008-08-05 $376,228,000
7332604 1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine Manuel de Lera Ruiz, Robert G. Aslanian, Michael Y. Berlin 2008-02-19 $85,332,000
7300941 Non-imidazole compounds Robert G. Aslanian, Neng-Yang Shih, Pauline C. Ting, Michael Y. Berlin, Stuart B. Rosenblum +5 more 2007-11-27 $287,299,000